it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done.
.
.
.
while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain.
.
.
.